Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in refractory or relapsed T-cell lymphoma
NCT00959686Phase 2Completed
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Sep 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in peripheral T-cell lymphoma (PTCL), cutaneous T-cell lymphoma (CTCL), sponsored by French Innovative Leukemia Organisation. Started Sep 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
peripheral T-cell lymphoma (PTCL)cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00959686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00959686.